Ya‐Hsun Kuo

Down-Regulation of Rad51 Expression Overcomes Drug Resistance to Gemcitabine in Human Non–Small-Cell Lung Cancer Cells

Min‐Shao Tsai, Ya‐Hsun Kuo, Yu‐Fan Chiu et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 89 citations

Medicine, Oncology, Pharmacology +17

Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2

Jen‐Chung Ko, Ying-Jhen Su, Szu‐Ting Lin et al. · Lung Cancer · 2009 · 53 citations

Life Sciences, Molecular Biology, Oncology +10

Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1)

Min‐Shao Tsai, Shao‐Hsing Weng, Ya‐Hsun Kuo et al. · Molecular Pharmacology · 2011 · 45 citations

Medicine, Cancer Biology, Oncology +14

Inhibition of p38 MAPK-Dependent Excision Repair Cross-Complementing 1 Expression Decreases the DNA Repair Capacity to Sensitize Lung Cancer Cells to Etoposide

Min‐Shao Tsai, Shao‐Hsing Weng, Huang-Jen Chen et al. · Molecular Cancer Therapeutics · 2011 · 40 citations

Medicine, Oncology, Pharmacology +15

Role of Rad51 Down-Regulation and Extracellular Signal-Regulated Kinases 1 and 2 Inactivation in Emodin and Mitomycin C-Induced Synergistic Cytotoxicity in Human Non–Small-Cell Lung Cancer Cells

Ying-Jhen Su, Min‐Shao Tsai, Ya‐Hsun Kuo et al. · Molecular Pharmacology · 2009 · 38 citations

Medicine, Cancer Biology, Oncology +17